Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2022 - 10 - 26 entities : Ligand pharmaceuticals incorporated save search
Viking Therapeutics Reports Third Quarter 2022 Financial Results and Provides Corporate Update
Published: 2022-10-26 (Crawled : 22:00) - biospace.com/
VKTX | $63.88 0.73% 0.72% 1.6M
|
Health Technology
|
| O: -2.2%
H: 12.5%
C: 3.75%
LGND | $68.58 -5.37% -5.67% 250K
|
Health Technology
|
| O: 0.48%
H: 2.13%
C: -0.81%
therapeutics financial update results
Ligand Announces that Janssen has Received Approval from U.S. FDA for TECVAYLI™ (teclistamab) for the Treatment of Patients with Relapsed or Refractory Multiple Myeloma
Published: 2022-10-26 (Crawled : 12:20) - biospace.com/
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
|
| O: 1.89%
H: 0.0%
C: 0.0%
AHPA 4 | $6.125 -9.26% 4.33%
|
|
| O: -5.1%
H: 1.72%
C: -8.48%
SNY | News | $47.125 1.78% 1.75% 2.1M
|
Health Technology
|
| O: 2.12%
H: 0.0%
C: 0.0%
LGND | $68.58 -5.37% -5.67% 250K
|
Health Technology
|
| O: 0.48%
H: 2.13%
C: -0.81%
treatment fda approval
Gainers vs Losers
| 75% | 25% |
Top 10 Gainers
MTTR | News M | $4.78 174.71% 63.6% 72M
|
AGBA | $2.565 105.2% 51.27% 200M
|
Finance
MLEC | $2.44 74.29% 42.62% 78M
|
n/a
EDBL | News | $6.28 67.02% 40.13% 16M
|
ATGL | $2.91 48.81% 32.8% 180K
|
ZAPP | $0.2175 47.16% 32.05% 16M
|
n/a
ONFO | $0.6075 38.38% 27.74% 7.3M
|
n/a
VIVK | $1.48 38.32% 27.7% 530K
|
Professional, Scientific, and T...
MNTS | $0.5 35.69% 26.3% 4.8M
|
SDIG A | $3.635 35.13% 26.0% 1M
|
Your saved searches
Save your searches and get alerts when important news are released.